Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Malignant Lymphoma

  Free Subscription


1 Am J Clin Pathol
2 Blood
2 Bone Marrow Transplant
1 Br J Haematol
1 Eur J Haematol
1 J Clin Oncol
1 J Virol
6 Leuk Lymphoma
4 Leukemia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Pathol

  1. CROTTY R, Hu K, Stevenson K, Pontius MY, et al
    Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay.
    Am J Clin Pathol. 2020 Dec 1. pii: 6014610. doi: 10.1093.
    PubMed         Abstract available


    BCL-2 inhibition in follicular lymphoma: can we tip the scales?
    Blood. 2020;136:2598-2600.

  3. VERGE V, Soufan R
    COVID-19-induced atypical pulmonary lymphocytes.
    Blood. 2020;136:2241.

    Bone Marrow Transplant

  4. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    PubMed         Abstract available

  5. DANYLESKO I, Shouval R, Shem-Tov N, Yerushalmi R, et al
    Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 3. pii: 10.1038/s41409-020-01156.
    PubMed         Abstract available

    Br J Haematol

  6. AHMED S, Glover P, Taylor J, Sha C, et al
    Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance.
    Br J Haematol. 2020 Nov 29. doi: 10.1111/bjh.17246.
    PubMed         Abstract available

    Eur J Haematol

  7. PICARDI M, Giordano C, Della Pepa R, Cerchione C, et al
    Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671."
    Eur J Haematol. 2020 Nov 30. doi: 10.1111/ejh.13558.
    PubMed         Abstract available

    J Clin Oncol

  8. CRUMP M
    Time to Change Direction in the Treatment of Relapsed Hodgkin Lymphoma?
    J Clin Oncol. 2020 Dec 4:JCO2002905. doi: 10.1200/JCO.20.02905.

    J Virol

  9. YETMING KD, Lupey-Green LN, Biryukov S, Hughes DJ, et al
    The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    J Virol. 2020;94.
    PubMed         Abstract available

    Leuk Lymphoma

  10. RODRIGUEZ-LOPEZ JL, Patel AK, Balasubramani GK, Glaser SM, et al
    Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?
    Leuk Lymphoma. 2020 Nov 30:1-11. doi: 10.1080/10428194.2020.1842398.
    PubMed         Abstract available

  11. PARKS AL, Kambhampati S, Fakhri B, Andreadis C, et al
    Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma.
    Leuk Lymphoma. 2020 Dec 1:1-6. doi: 10.1080/10428194.2020.1852474.

  12. BALLAS LK, Metzger ML, Milgrom SA, Advani R, et al
    Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria.
    Leuk Lymphoma. 2020 Dec 4:1-14. doi: 10.1080/10428194.2020.1852559.
    PubMed         Abstract available

  13. DI ROCCO A, Cuneo A, Di Rocco A, Merli F, et al
    Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy.
    Leuk Lymphoma. 2020 Dec 4:1-11. doi: 10.1080/10428194.2020.1849676.
    PubMed         Abstract available

  14. MORIGI A, Casadei B, Argnani L, Stefoni V, et al
    Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma.
    Leuk Lymphoma. 2020 Dec 4:1-3. doi: 10.1080/10428194.2020.1855342.

  15. FOX TA, Carpenter B, Taj M, Perisoglou M, et al
    Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma.
    Leuk Lymphoma. 2020 Dec 4:1-6. doi: 10.1080/10428194.2020.1855346.


  16. WANG Y, Liu Y, Tan X, Pan B, et al
    Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection.
    Leukemia. 2020;34:2704-2707.
    PubMed         Abstract available

  17. BALINAS-GAVIRA C, Rodriguez MI, Andrades A, Cuadros M, et al
    Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
    Leukemia. 2020;34:2722-2735.
    PubMed         Abstract available

  18. YANG C, Xie M, Zhang K, Liu H, et al
    Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.
    Leukemia. 2020;34:3055-3059.

  19. LIBERT D, Yuan CM, Masih KE, Galera P, et al
    Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy.
    Leukemia. 2020;34:3064-3069.

    PLoS One

  20. PASQUAL E, Turner MC, Gracia-Lavedan E, Casabonne D, et al
    Correction: Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study.
    PLoS One. 2020;15:e0243396.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.